ESTIMATING THE RISK OF ANGIOEDEMA ASSOCIATED WITH USE OF DIPEPTIDYL-PEPTIDASE INHIBITORS
Author(s)
Ramachandran S
University of Mississippi, University, MS, USA
OBJECTIVES: To estimate the risk of angioedema and angioedema related side-effects caused by the use of dipeptidylpeptidase inhibitors(DPP-4), angiotensin converting enzyme inhibitors (ACEI) and their interaction in patients suffering from diabetes and/or hypertension. METHODS: A retrospective analysis employing a case control design was performed using Mississippi Medicaid fee-for-service data from January 1st
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PCV8
Topic
Epidemiology & Public Health
Topic Subcategory
Safety & Pharmacoepidemiology
Disease
Cardiovascular Disorders, Diabetes/Endocrine/Metabolic Disorders